# Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]

> **NCT00404378** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 15 (actual)

## Conditions studied

- Nausea and Vomiting, Chemotherapy-Induced

## Interventions

- **DRUG:** ketoconazole
- **DRUG:** casopitant 100 mg
- **DRUG:** Casopitant 50 mg

## Key facts

- **NCT ID:** NCT00404378
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10-20
- **Primary completion:** 2007-01-05
- **Final completion:** 2007-01-05
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2017-09-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404378, "Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00404378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*